Clinical Trial Update: GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating an investigational GA agent in newly diagnosed diffuse large B-cell lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• GA investigational agent

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Diffuse Large B Cell Lymphoma CD20 Positive | Phase 3 | Status: TERMINATED